# Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive

> **NCT00945880** · PHASE1 · COMPLETED · sponsor: **Eiger BioPharmaceuticals** · enrollment: 12 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** clemizole hydrochloride

## Key facts

- **NCT ID:** NCT00945880
- **Lead sponsor:** Eiger BioPharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945880, "Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00945880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*